Akero Therapeutics

Akero Therapeutics is a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH). We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full corporate rebrand that included a positioning platform, identity system and company website among other touch points.